Jeff Willis is a global development leader and group medical director specializing in obesity and metabolism, as well as a retinal medicine expert. They have over 10 years of experience in the biotech and pharmaceutical sectors, notably at Genentech, where they led initiatives from conception to regulatory approval, enhancing patient outcomes and treatment efficacy. Jeff began their career at the World Bank while pursuing a PhD, completed an ophthalmology residency at the University of California, Davis, and then joined Genentech to advance innovative ophthalmology research. Currently, they oversee clinical trials for CT-388, aimed at treating obesity and obesity-related complications.
This person is not in the org chart
This person is not in any teams
This person is not in any offices